Literature DB >> 2408798

Selective depression of thymus-independent anti-DNP antibody responses induced by adult but not neonatal splenectomy.

D Gray, D Chassoux, I C MacLennan, H Bazin.   

Abstract

The effect of splenectomy was assessed on rats' capacity to respond to 2,4-dinitrophenol (DNP) conjugated to spider crab haemocyanin (MSH) or hydroxyethyl starch (HES). The response to DNP-HES was profoundly suppressed in all immunoglobulin classes and subclasses by adult splenectomy. This loss of responsiveness increased with time after removal of the spleen. By contrast no significant effect on the anti-DNP-MSH response was caused by splenectomy. Experiments in congenitally athymic rats confirmed the thymus dependency of anti-DNP antibody responses of all classes and subclasses induced by DNP-MSH. DNP-HES responses, however, were elevated in athymic animals. The effect of adult splenectomy in these animals was considerably less than that produced in euthymic rats. Neonatal splenectomy in euthymic rats only resulted in minor impairment of these rats' capacity to respond to DNP-HES as adults, indicating the ability of rats to compensate after neonatal but not adult splenectomy. These data are taken to show that the spleen plays an important role in responses against this thymus-independent type II antigen which is only partially replaceable by other compartments of the immune system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408798      PMCID: PMC1576989     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.

Authors:  H KING; H B SHUMACKER
Journal:  Ann Surg       Date:  1952-08       Impact factor: 12.969

2.  Cloning of B cells positive or negative for surface IgD. II. Triggering and tolerance in the T-dependent splenic focus assay.

Authors:  J E Layton; J M Teale; G J Nossal
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

3.  Macrophage activation in mice lacking thymus-derived (T) cells.

Authors:  R M Zinkernagel; R V Blanden
Journal:  Experientia       Date:  1975-05-15

4.  Distinct delta + and delta - B-lymphocyte lineages in the rat.

Authors:  H Bazin; D Gray; B Platteau; I C MacLennan
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 5.  Postsplenectomy infection.

Authors:  E L Francke; H C Neu
Journal:  Surg Clin North Am       Date:  1981-02       Impact factor: 2.741

6.  Marginal zones: the major B cell compartment of rat spleens.

Authors:  D S Kumararatne; H Bazin; I C MacLennan
Journal:  Eur J Immunol       Date:  1981-11       Impact factor: 5.532

7.  T cell control of the antibody response to the T-independent antigen, DAGG-Ficoll.

Authors:  A A Nordin; M H Schreier
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

8.  Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal-zone macrophages.

Authors:  J H Humphrey; D Grennan
Journal:  Eur J Immunol       Date:  1981-03       Impact factor: 5.532

9.  Tolerogenic or immunogenic activity of hapten-conjugated polysaccharides correlated with cellular localization.

Authors:  J H Humphrey
Journal:  Eur J Immunol       Date:  1981-03       Impact factor: 5.532

10.  Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency.

Authors:  J Slack; G P Der-Balian; M Nahm; J M Davie
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  14 in total

1.  The spleen? Who needs it anyway?

Authors:  M Hazlewood; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Glycosyl receptors in macrophage subpopulations of rat spleen and lymph node. A comparative study using neoglycoproteins and monoclonal antibodies ED1, ED2 and ED3.

Authors:  G Harms; C D Dijkstra; M J Hardonk
Journal:  Cell Tissue Res       Date:  1990-10       Impact factor: 5.249

3.  Importance of macrophage inflammatory protein-1α and splenic macrophages in neurodegeneration induced by PVC-211 murine leukemia virus.

Authors:  Xiujie Li; Xiang Zhang; Joan L Cmarik; Sandra Ruscetti
Journal:  Virology       Date:  2010-11-04       Impact factor: 3.616

4.  Fetal and neonatal development of human spleen: an immunohistological study.

Authors:  W Timens; T Rozeboom; S Poppema
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

5.  Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA.

Authors:  P J Lane; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

6.  Effects of chronic injection of sphingomyelin-containing liposomes on lymphoid and non-lymphoid cells in the spleen. Transient suppression of marginal zone macrophages.

Authors:  E Claassen; Y Westerhof; B Versluis; N Kors; M Schellekens; N van Rooijen
Journal:  Br J Exp Pathol       Date:  1988-12

7.  Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens.

Authors:  L Nitschke; M H Kosco; G Köhler; M C Lamers
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria.

Authors:  R J Holdsworth; H McKenzie; D Parratt; A D Irving; A Cuschieri
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

9.  Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect.

Authors:  W Timens; R Leemans
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

10.  Hypogammaglobulinaemia in nephrotic rats is attributable to hypercatabolism of IgG.

Authors:  M Beaman; S Oldfield; I C MacLennan; J Michael; D Adu
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.